Condition
Superior Mesenteric Artery Syndrome
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07317076Not ApplicableRecruiting
GT Metabolic Magnet System in Adults With Gastrointestinal Disorders
NCT06970093Not ApplicableCompletedPrimary
Comparison of One Anastomisis Gastric Bypass and Duodeno-Jejunostomy for Treating SMA Syndrome
NCT07115472Not ApplicableCompletedPrimary
Fluoxetine in Refractory Superior Mesenteric Artery Syndrome by Targeting Comorbid Somatic Symptom Disorder
NCT04515251RecruitingPrimary
Ultrasound Evaluation of Superior Mesenteric Artery Measurements in a Healthy Pediatric Population
NCT03416647Not ApplicableCompletedPrimary
SMAS: a Prospective Study in a Single Institution
Showing all 5 trials